Jean-Charles Soria, MD, PhD, began serving as editor-in-chief of Annals of Oncology, the flagship publication of the European Society of Medical Oncology (ESMO), at the beginning of January. He succeeds Jan B. Vermorken, MD, PhD.
A medical oncologist specializing in lung cancer, Soria has been a professor of oncology at France's South Paris University since 2006 and was recently appointed chair of the new drug development department at Gustave Roussy Cancer Center in Paris. He holds an adjunct professorship at The University of Texas MD Anderson Cancer Center in Houston, where he completed a postdoctoral fellowship in the department of thoracic, head and neck medical oncology.
Soria's main research interests include early clinical development of therapies for solid tumors, pharmacodynamic biomarkers, and translational research related to tumor progression in models of lung cancer. He has published more than 330 scientific articles.
Rolf A. Stahel, MD, began a 2-year term as president of ESMO on January 1. He succeeds Martine Piccart, MD, PhD.
Stahel heads the Center for Lung and Thoracic Oncology and serves as senior staff physician at the Clinic of Oncology at the University Hospital of Zurich, Switzerland. He holds the title of professor of medicine at the University of Zurich. A founding member and the first president of the Swiss Society for Medical Oncology, he served as president of the Swiss Institute for Applied Cancer Research from 1999 to 2005.
In addition to his clinical activities, Stahel conducts translational research related to thoracic malignancies, particularly pleural mesothelioma, and was part of the group that authored the ESMO guidelines for the diagnosis, treatment, and follow-up of patients with the disease.
For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.